...
首页> 外文期刊>Experimental Physiology >Phosphatidylinositol 3-kinase and ERK1/2 are not involved in adenosine A1, A2A or A3 receptor-mediated preconditioning in rat ventricle strips.
【24h】

Phosphatidylinositol 3-kinase and ERK1/2 are not involved in adenosine A1, A2A or A3 receptor-mediated preconditioning in rat ventricle strips.

机译:磷脂酰肌醇3-激酶和ERK1 / 2不参与大鼠心室条带中腺苷A1,A2A或A3受体介导的预处理。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase 1 and 2 (ERK1/2) and phosphatidylinositol 3-kinase (PI3-kinase)/protein kinase B (PKB; also known as Akt) are important antiapoptotic signalling pathways which have recently been implicated in cardioprotection. However, at present the involvement of ERK1/2 and PI3-kinase/PKB in adenosine receptor-mediated cardioprotection is poorly understood. In this study we used isolated rat right ventricular strips, contracted by electrical-field stimulation, in order to investigate the role of ERK1/2 and PI3-kinase/PKB in adenosine receptor-induced cardioprotection. Ventricle strips were pretreated for 2 min with the agonists adenosine (non-selective), CPA (A1 selective), CGS 21680 (A2A selective) and Cl-IB-MECA (A3 selective) before 30 min hypoxia followed by 30 min reoxygenation. Each agonist significantly improved posthypoxic percentage contraction recovery compared to control strips. Similarly hypoxic preconditioning (10 min hypoxia followed by 20 min reoxygenation) significantly improved posthypoxic percentage contraction recovery compared to non-preconditioned strips. The selective adenosine receptor antagonists DPCPX (A1), ZM 241385 (A2A) and MRS 1220 (A3) attenuated cardioprotection induced by CPA, CGS 21680 and Cl-IB-MECA, respectively. Pre-incubation (30 min) of ventricle strips with the MEK1 inhibitor PD 98059 (50 microM) or the PI3-kinase inhibitor wortmannin (100 nM) significantly reduced posthypoxic percentage contraction recovery induced by hypoxic preconditioning. In contrast, PD 98059 and wortmannin had no significant effect on cardioprotection induced by CPA, Cl-IB-MECA or CGS 21680. Overall these data indicate that although selective A1, A2A and A3 adenosine receptor agonists induce preconditioning in rat right ventricular strips the effects are independent of ERK1/2- and PI3-kinase-dependent pathways. In contrast ERK1/2 and PI3-kinase-dependent pathways do appear to be involved in early hypoxic preconditioning.
机译:丝裂原活化蛋白激酶激酶(MEK)/细胞外信号调节激酶1和2(ERK1 / 2)和磷脂酰肌醇3-激酶(PI3-激酶)/蛋白激酶B(PKB;也称为Akt)是重要的抗凋亡信号通路最近与心脏保护有关。然而,目前对ERK1 / 2和PI3-激酶/ PKB在腺苷受体介导的心脏保护中的参与了解甚少。在这项研究中,我们使用分离的大鼠右心室带,通过电场刺激收缩,以研究ERK1 / 2和PI3-激酶/ PKB在腺苷受体诱导的心脏保护中的作用。在缺氧30分钟之前,先用激动剂腺苷(非选择性),CPA(A1选择性),CGS(21 A2A选择性)和Cl-IB-MECA(A3选择性)对心室条预处理2分钟,然后再进行30分钟复氧。与对照试纸条相比,每种激动剂均显着改善了低氧后的收缩率恢复率。同样,低氧预处理(10分钟缺氧,然后再进行20分钟复氧)与未预处理的胶条相比,明显改善了低氧后的收缩率恢复率。选择性腺苷受体拮抗剂DPCPX(A1),ZM 241385(A2A)和MRS 1220(A3)分别减弱了CPA,CGS 21680和Cl-IB-MECA诱导的心脏保护作用。用MEK1抑制剂PD 98059(50 microM)或PI3激酶抑制剂渥曼青霉素(100 nM)预孵育心室带(30分钟)可显着降低由低氧预处理引起的低氧后收缩恢复率。相反,PD 98059和渥曼青霉素对CPA,Cl-IB-MECA或CGS 21680诱导的心脏保护作用没有显着影响。总体而言,这些数据表明,尽管选择性的A1,A2A和A3腺苷受体激动剂在大鼠右心室带中引起预处理,但其作用独立于ERK1 / 2和PI3激酶依赖性途径。相反,ERK1 / 2和PI3激酶依赖性途径似乎确实参与了早期低氧预处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号